Clinical Trial Update: A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study evaluating Hectorol and Zemplar injections in CKD patients on hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism

Drugs mentioned

• Hectorol (doxercalciferol)
• Zemplar (Paricalcitol)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Secondary Hyperparathyroidism | Phase 4 | Status: COMPLETED